The present study compares the effect of a single bout of sprint interval cycling against continuous cycling on postprandial lipaemia. Participants were nine healthy volunteers (five male), aged 20-26 years. Each participant undertook three 2-d trials in a random order. On day 1, participants rested (control), undertook a single 20 minute bout of continuous cycling at 70% of maximum oxygen uptake or completed four 30-second bouts of sprint interval cycling on a cycle ergometer, separated by 4.5 minutes of recovery. On day 2, participants rested and consumed a test meal (75% fat). Triacylglycerol concentrations were measured fasting and for 6 hours after the meal. The total area under the triacylglycerol concentration against time curve was similar among trials (mean (SD): control, 9.51 (3.50) mmol · l(-1) compared with continuous cycling, 8.58 (3.08) mmol · l(-1) compared with sprint interval cycling, 9.28 (1.89) mmol · l(-1); P = 0.517). There was no difference in the pattern of TAG response to the test meal among trials (trial × time interaction, P = 0.637). The present study found no effect of sprint interval or continuous cycling on postprandial lipaemia, with the reason for this finding unclear. Future studies need to more precisely determine the relationship between exercise and postprandial lipaemia across different types of exercise.
These findings demonstrate that 30 min of brisk walking is sufficient to improve insulin sensitivity in healthy, young Asians but only continuous and not accumulated walking provides this benefit. Further studies are needed to determine if accumulated and continuous exercise have different chronic effects on insulin sensitivity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.